Eribulin mesylate (halichondrin B analog E7389) in platinum-sensitive ovarian cancer: A phase II study, CTEP #7431 Meeting Abstract
| Authors: | Hensley, M. L.; Kravetz, S. J.; Jia, X.; Tew, W. P.; Pereira, L.; Sabbatini, P.; Whalen, C.; Aghajanian, C.; Zarwan, C.; Berlin, S. T. |
| Abstract Title: | Eribulin mesylate (halichondrin B analog E7389) in platinum-sensitive ovarian cancer: A phase II study, CTEP #7431 |
| Meeting Title: | 47th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 29 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2011 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2011-05-20 |
| Language: | English |
| ACCESSION: | WOS:000208880301623 |
| DOI: | 10.1200/jco.2011.29.15_suppl.5090 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 5090 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
